Prohibits an individual from utilizing the deduction for any month in which the taxpayer is covered for long-term care under a health plan maintained by any employer of the taxpayer or of the taxpayer's spouse in which 50 percent or more of the cost is incurred by the employer. Forbids any amount taken into account for the purposes of the long-term care deduction from also being taken into account for a deduction for medical expenses or self-employed health care expenses. Requires married couples to file a joint return to receive the deduction. Permits the deduction whether or not a taxpayer itemizes.
(Sec. 3) Allows an additional personal exemption for each "qualified family member" with "long-term needs" who resides in a taxpayer's home.
Defines an individual with "long-term care needs" as someone who: (1) has been certified by a physician as being unable, for at least 180 consecutive days, to perform at least two activities of daily living due to loss of functional capacity; or (2) requires substantial supervision due to severe cognitive impairment and needs reminding or cuing assistance to perform at least one activity of daily living; or (3) is unable to engage in age appropriate activities. Sets the amount of exemption at $500 for 2003, rising gradually to $2,500 for 2011.
Prohibits the exemption unless a taxpayer includes with a return the name and taxpayer identification number of the physician certifying the member of the household in need. Allows exception to such requirement if due diligence in attempting to provide such information is shown.
(Sec. 4) Modifies consumer protection provisions for long-term care insurance. Revises provisions pertaining to the excise tax on providers of long-term care insurance who fail to meet certain standards, adding requirements about disclosure of rating practices to the consumer and about suitability.
(Sec. 5) Expands qualifying expenses for the 50-percent tax credit related to human clinical testing of drugs for the treatment of certain rare diseases and conditions. Includes for the purpose of calculating the credit expenses incurred after the date on which a taxpayer files an application with the Food and Drug Administration for designation of a drug as a potential treatment for a rare disease or disorder under the Federal Food, Drug, and Cosmetic Act. Allows the credit to be taken when a drug is designated as such not later than the due date (including extensions) for the individual's tax return for the year in which the application was filed (currently only expenses incurred after a drug is approved as a potential treatment qualify for the credit).
(Sec. 6) Includes any vaccine against hepatitis A under the 75-cents-per-dose manufacturer's excise tax.
(Sec. 7) Treats individuals covered under a Medicare+Choice medical savings account (MSA) plan as having high deductible health plans for purposes of archer MSA, thus permitting such Medicare+Choice individuals to qualify for Archer MSA. Sets a figure of 100 percent of the deductible under the Medicare+Choice policy as the maximum deductible contribution that can be made to an Archer MSA with respect to a Medicare-eligible individual.